Review




Structured Review

MISSION Therapeutics uchl1 small-molecule probes and inhibitors
Uchl1 Small Molecule Probes And Inhibitors, supplied by MISSION Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uchl1+small-molecule+probes+and+inhibitors/uchl1+small+molecule+probes+and+inhibitors/pm34497382-130-20-8
Average 90 stars, based on 1 article reviews
uchl1 small-molecule probes and inhibitors - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Activity Assay:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Ubiquitin Proteomics:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Fluorescence:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Negative Control:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Western Blot:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

SDS Page:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Mass Spectrometry:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Lysis:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Ligation:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Liquid Chromatography:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Modification:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Imaging:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

In Vivo:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].

Microscopy:

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [ ].

Article Title: UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Article Snippet: In parallel, Panyain et al. in collaboration with Mission Therapeutics reported high quality, low nanomolar activity UCHL1 small-molecule probes and inhibitors, which target UCHL1 with minimal off-target activity, providing the most potent and selective tools currently available to probe UCHL1 in cancer [77].



Similar Products

90
MISSION Therapeutics uchl1 small-molecule probes and inhibitors
Uchl1 Small Molecule Probes And Inhibitors, supplied by MISSION Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uchl1+small-molecule+probes+and+inhibitors/uchl1+small+molecule+probes+and+inhibitors/pm34497382-130-20-8
Average 90 stars, based on 1 article reviews
uchl1 small-molecule probes and inhibitors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results